Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified T lymphocytes comprising an inducible caspase and methods of apoptosis

Modified T lymphocytes comprising an inducible caspase and methods of apoptosis

US Patent 10238690 · Granted Mar 26, 2019

Estimated economic value: $480,718,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

T lymphocyte production methods and t lymphocytes produced thereby2023
Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods 2023
Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods 2023
Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods 2023
Methods of improving vector transduction efficiency into T lymphocytes2023
Enhanced placental stem cells and uses thereof2022
Chimeric antigen receptors2021
Chimeric antigen receptors2021
Chimeric antigen receptors2021
Methods of improving vector transduction efficiency into T lymphocytes2021
Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods 2021
Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods 2021